Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Elixir Department: SOP for Prevention of Aeration During Mixing – V 2.0

Posted on By

Elixir Department: SOP for Prevention of Aeration During Mixing – V 2.0

Standard Operating Procedure for Prevention of Aeration During Mixing in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/067/2025
Supersedes SOP/ELX/067/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure for preventing aeration during the mixing of elixir formulations, ensuring product clarity, stability, and prevention of oxidative degradation.

2. Scope

This SOP applies to all elixir formulations mixed using mechanical or magnetic stirrers in the Elixir Department, especially those containing alcohol, volatile agents, or oxidation-sensitive APIs.

3. Responsibilities

  • Production Operator:
    • Set and monitor agitation speed to minimize vortex formation.
    • Ensure proper flow direction and baffling to reduce air entrapment.
  • Production Supervisor:
    • Verify mixing parameters and ensure SOP compliance.
  • QA Officer:
    • Inspect batches for signs of aeration and confirm corrective actions if needed.
See also  Elixir Department: SOP for Issuance of Raw Materials for Elixir Production - V 2.0

4. Accountability

The Production Head is accountable for ensuring that aeration control is implemented during mixing operations and deviations are addressed as per CAPA.

5. Procedure

5.1 Equipment Setup

  1. Ensure use of a mixing tank
with bottom entry agitator or deflector baffles if available.
  • Verify that impeller type (e.g., marine propeller, anchor blade) is suitable for low shear mixing.
  • Ensure the tank is filled to at least 60% of its working volume before starting agitation to avoid vortex formation.
  • 5.2 Agitation Control

    1. Start mixing at low RPM (e.g., 40–60 RPM).
    2. Avoid rapid changes in agitation speed that could pull air into the solution.
    3. Gradually increase speed if necessary, but do not exceed 100 RPM unless validated for the product.

    5.3 Ingredient Addition Technique

    1. Add ingredients close to the tank wall instead of directly into the vortex.
    2. Use submerged addition where feasible—add materials using dip tubes or bottom entry ports to reduce splashing and air incorporation.

    5.4 Observation and Inspection

    1. Visually check the batch for signs of foam or bubbles during and after mixing.
    2. If bubbles are observed:
      • Reduce agitation speed immediately.
      • Allow the solution to stand until air escapes naturally.
      • In critical cases, apply vacuum de-aeration (if validated).

    5.5 Documentation

    1. Record mixing speed, duration, temperature, and aeration observations in the Mixing Control Log (Annexure-1).
    2. If de-aeration was required, document in the De-Aeration Log (Annexure-2).

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QA: Quality Assurance
    • CAPA: Corrective and Preventive Action
    • RPM: Revolutions Per Minute

    7. Documents

    1. Mixing Control Log (Annexure-1)
    2. De-Aeration Log (Annexure-2)
    3. BMR – Mixing Section

    8. References

    • ICH Q8(R2) – Pharmaceutical Development
    • WHO GMP Guidelines – Liquid Dosage Manufacturing

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Mixing Control Log

    Date Batch No. RPM Duration (min) Aeration Observed Operator Verified By
    11/04/2025 ELX-1012 60 30 No Rajesh Kumar Sunita Reddy

    Annexure-2: De-Aeration Log

    Date Batch No. Method Used Duration Remarks Approved By
    11/04/2025 ELX-1012 Natural Standing 10 min Minor foam resolved Sunita Reddy

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial Release New SOP QA Head
    11/04/2025 2.0 Included De-Aeration Log and Preventive Steps GMP Enhancement QA Head
    See also  Elixir Department: SOP for Handling of Spillage During Dispensing - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: BA-BE Studies: SOP for Ongoing Subject Medical Surveillance – V 2.0
    Next Post: Analytical Method Development: Specificity Study Using HPLC – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version